OBJECTIVE: To develop through consensus and literature review management options for women with a hereditary predisposition to ovarian cancer, outcomes of interest were incidence of ovarian cancer, life expectancy, additional benefits of prophylactic oophorectomy, complications of surgery, and alternatives to prophylactic oophorectomy. METHODS: MEDLINE, CANCERLIT, and the Cochrane Library databases were searched to September 2003 using the terms ovarian, cancer, neoplasms, prophylactic oophorectomy, ovariectomy, clinical trial, metaanalysis, and systematic review. RESULTS: Four cohort studies (two retrospective, two prospective) examined whether prophylactic oophorectomy reduced the lifetime risk of developing ovarian cancer. All the cohort studies found that prophylactic oophorectomy reduced the lifetime risk of developing ovarian cancer; however, this risk reduction was statistically significant in only two cohort studies. The complication rate of laparoscopic surgery for prophylactic oophorectomy is low (0.22-4.0%). However, there are long-term adverse effects of prophylactic oophorectomy, most notably the onset of early menopause. CONCLUSIONS: Based on the evidence from the four cohort studies, prophylactic oophorectomy does protect against the development of ovarian cancer.
OBJECTIVE: To develop through consensus and literature review management options for women with a hereditary predisposition to ovarian cancer, outcomes of interest were incidence of ovarian cancer, life expectancy, additional benefits of prophylactic oophorectomy, complications of surgery, and alternatives to prophylactic oophorectomy. METHODS: MEDLINE, CANCERLIT, and the Cochrane Library databases were searched to September 2003 using the terms ovarian, cancer, neoplasms, prophylactic oophorectomy, ovariectomy, clinical trial, metaanalysis, and systematic review. RESULTS: Four cohort studies (two retrospective, two prospective) examined whether prophylactic oophorectomy reduced the lifetime risk of developing ovarian cancer. All the cohort studies found that prophylactic oophorectomy reduced the lifetime risk of developing ovarian cancer; however, this risk reduction was statistically significant in only two cohort studies. The complication rate of laparoscopic surgery for prophylactic oophorectomy is low (0.22-4.0%). However, there are long-term adverse effects of prophylactic oophorectomy, most notably the onset of early menopause. CONCLUSIONS: Based on the evidence from the four cohort studies, prophylactic oophorectomy does protect against the development of ovarian cancer.
Authors: Yoland C Antill; John Reynolds; Mary Anne Young; Judy A Kirk; Katherine M Tucker; Tarli L Bogtstra; Shirley S Wong; Tracy E Dudding; Juliana L Di Iulio; Kelly-Anne Phillips Journal: Fam Cancer Date: 2006-07-07 Impact factor: 2.375
Authors: Phuong L Mai; Marion Piedmonte; Paul K Han; Richard P Moser; Joan L Walker; Gustavo Rodriguez; John Boggess; Thomas J Rutherford; Oliver Zivanovic; David E Cohn; J Tate Thigpen; Robert M Wenham; Michael L Friedlander; Chad A Hamilton; Jamie Bakkum-Gamez; Alexander B Olawaiye; Martee L Hensley; Mark H Greene; Helen Q Huang; Lari Wenzel Journal: Gynecol Oncol Date: 2017-02-10 Impact factor: 5.482
Authors: Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly Journal: Gynecol Oncol Date: 2009-01-13 Impact factor: 5.482
Authors: Domenico Coppola; Santo V Nicosia; Andrea Doty; Thomas A Sellers; Ji-Hyun Lee; Jimmy Fulp; Zachary Thompson; Sanja Galeb; John McLaughlin; Steven A Narod; Joellen Schildkraut; Tuya Pal Journal: Anticancer Res Date: 2012-11 Impact factor: 2.480
Authors: B E Kiely; M L Friedlander; R L Milne; L Stanhope; P Russell; M A Jenkins; P Weideman; S A McLachlan; P Grant; J L Hopper; K A Phillips Journal: Fam Cancer Date: 2011-09 Impact factor: 2.375
Authors: Bernadette A M Heemskerk-Gerritsen; Cecile T M Brekelmans; Marian B E Menke-Pluymers; Albert N van Geel; Madeleine M A Tilanus-Linthorst; Carina C M Bartels; Murly Tan; Hanne E J Meijers-Heijboer; Jan G M Klijn; Caroline Seynaeve Journal: Ann Surg Oncol Date: 2007-05-31 Impact factor: 5.344